# U. S. Diagnostics, Inc.

- Location (FDA's records): San Luis Obispo, CA
- FDA decisions: 22 (1986–2011): 22 510(k) clearances
- Product codes: JPA (4), NBW (3), JJY (2), JJT (2), CGA (2), CHH (1), CDL (1), CDT (1), CJE (1), KNK (1), KRZ (1), GJS (1)
- Predicates its devices cite: 10 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Lifescan, Inc.: 6 (https://510kreport.com/company/lifescan)
- Roche Diagnostics Corp.: 3 (https://510kreport.com/company/roche-diagnostics)

## Its most-cited devices
- K082201: G5 Infinity Blodo Glucose Monitoring System with Model Igm, 0024A (2009), cited by 1

## Recent decisions
- K110435: Easygluco Plus Blood Glucose Monitoring System (Sep 21, 2011)
- K082201: G5 Infinity Blodo Glucose Monitoring System with Model Igm, 0024A (Feb 20, 2009)
- K061431: Easygluco, Model Igm-0002 G2 (Jan 12, 2007)
- K051651: G4, Model Igm-0004 (Apr 14, 2006)
- K870686: Coagulation Control, Level II (Apr 20, 1987)
- K870685: Coagulation Control, Level I (Apr 20, 1987)
- K870687: Coagulation Control, Level Iii (Apr 20, 1987)
- K870596: Prothrombin Time Test (Apr 20, 1987)

Source page: https://510kreport.com/company/u-s-diagnostics